2020年11月14日全球新冠肺炎(COVID-19)疫情简报,确诊超5371万,日新增与死亡均再创新高

2020-11-14 MedSci整理 MedSci整理

据称Worldometers实时统计数据显示,截至北京时间11月14日07时28分,全球新冠肺炎(COVID-19)确诊病例达5371万例,新增641,715例至53,717,443例,死亡病例达12

据称Worldometers实时统计数据显示,截至北京时间11月14日07时28分,全球新冠肺炎COVID-19)确诊病例达5371万例,新增641,715例至53,717,443例,死亡病例达129万例,新增9,803例至1,308,430 例,康复37,477,310例,重症与危重症病人达到109,157例。昨日新增再次突破60万人,达到641,715,其中美国创纪录达到日新增175,439人,目前美国每百万人口确诊为33330人。最严重的是安道尔,每百万人口感染超过7万人。全球疫情形势整体趋于恶化,从曲线上看,仍然处于持续增长之中。全球确诊病例超过10万例的国家增至57个。昨日报道:2020年11月13日全球新冠肺炎(COVID-19)疫情简报,确诊超5303万,各方期待疫苗问世

疫情最严重国家,多国确诊人数超过4%

安道尔每百万人确诊74,052人,即全国7.4%人群已确诊感染。按每百万人口计算,法属波利尼西亚达到41,583人,黑山共和国达到41,569人,巴林达到48,966人,捷克达到42,029人,比利时达到44,830人,美国达到33330人。前期严重的冰岛,目前为15,114人。

美国连续多日新增超过10万,疫情反弹严重

欧洲第二波疫情:单日新增感染数突破18万

据《日经新闻》报道,12日,包括欧盟和英国在内,欧洲的单日新曾确诊感染者人数约18.3万人,7天平均日增感染者人数约16.6万人。欧洲疫情最严重的国家是意大利。12日,英国新确诊感染者人数为3.3万人,成为疫情暴发以来的最高值。英国卫生当局的负责人表示:“感染率在上升是非常明显的事,所以让它降下来非常重要。只有这样才能减少死亡人数,缓解医院的压力。”

意大利疫情远超第一播。

日本第三波疫情:单日新增刷新8月纪录

据日本NHK报道,12日日本全国单日新确诊的新冠病毒感染者人数为1643人,超过了8月7日1605人的最高纪录。另外,日本首都东京12日的单日新增感染者人数为393人,刷新了8月8日429人的最高纪录。

日本东京大学附属医学院河冈义裕教授教授带领的研究团队发现,现在全世界正在流行的新冠病毒跟疫情初期的新冠病毒相比,已经发生了变异,传染性变得更强了。他的这项研究已经发布在了13日的《科学杂志》的电子版上。

据报道,河冈教授的研究团队发现,现在的新冠病毒跟疫情初期的相比,与传染相关的蛋白质已经发生了变异。这种变异后的新冠病毒主要以欧洲为起点,开始向全世界传播。河冈教授表示,这种变异可能会造成传染性很高。

全球10 支新冠疫苗已进入临床 III 期

根据WHO 官网数据发现,全球在研新冠疫苗中共计有10 支已进入临床 III 期, 4支来自中国,其余分别来自美、德、英、俄。

根据世界卫生组织数据,目前已进入三期临床试验阶段的四支中国新冠疫苗分别为:中国军科院和康希诺共同研制的腺病毒载体疫苗、北京生物制品研究所和国药集团共同研制的灭活疫苗、武汉生物制品研究所和国药集团共同研制的灭活疫苗以及科兴中维的灭活疫苗。

国务院联防联控机制科研攻关组疫苗研发专班工作组组长、国家卫健委医药卫生科技发展研究中心主任郑忠伟在回应新冠疫苗产能问题时提到,预计到今年年底,我国新冠疫苗的年产能能达到6.1亿剂,明年,我国新冠疫苗年产能在此基础上会有效扩大,来切实保证我国以及全球其他国家对中国新冠疫苗的需求。

德国56%重症新冠状动脉患者需要接受呼吸机

德国重症和急诊医学跨学科协会12日表示,当天当天,德国有3186名新冠状肺炎患者正在接受重症监护室接受治疗,这是自新冠状肺炎疫情暴发以来,德国 重症监护病房中新冠肺炎患者人数最多的一次。数据还显示,在重症病房中,有56%的患者需要呼吸呼吸机。 目前,德国仍有6600个重症监护室床位使用。。不过,德国卫生部长施潘当天警告称,如果感染率继续以当前水平上升,德国重症监护病房将不堪重负。

外交部回应巴西派团来华考察新冠疫苗:愿提供必要的便利

有记者就巴西卫生监督机构将派团来华考察新冠肺炎疫苗研发向发言人质疑。 这项,外交部部长汪文斌表示,疫苗研发对新冠状肺炎疫情的防控实质,中国新冠状疫苗自主研发在世界领先地位。这项初步高度评价。中方愿遵循国内相关法律法规和国际惯例,为巴西卫生监管机构派团来华提供必要的便利。

张文宏谈上海为何没有全员筛检:延续精准防控,早发现快追踪

11月13日财新峰会上,张文宏临近最近上海出现的一例新冠状动脉,并出现大规模全员筛检,,没有非常紧张,都是因为一直延续着精准防控的策略,早期发现,快速追踪,锁定病毒蔓延位置,然后以这个位置为核心展开筛查

济南进口冷冻食品及包装标本检出阳性

据济南市卫健委,11月13日下午5时,济南市疾控中心在盖世物流园区冷库储存的进口冷冻食品及包装标本检测中新冠状病毒核酸阳性 济南市委员会统筹基金疫情防控和经济运行工作领导小组(指挥部)立即启动应急响应,该园区实施全封闭管控,涉及货物进行封存,对所有接触人员及相关人员进行相关核酸检测和健康管理,追踪货物 流向并发出协查通知函,对盖世物流园区冷库进行全面消灭。总体货物溯源流向情况已基本掌握,相关的抗疫情防控工作正在有序进行中,有关信息将及时向社会公布。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=899060, encodeId=0a0689906088, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>,一些小国可以验证<a href='/topic/show?id=44aa800289b' target=_blank style='color:#2F92EE;'>#群体免疫#</a>的作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=1201, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=80028, encryptionId=44aa800289b, topicName=群体免疫)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Nov 14 08:44:35 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899449, encodeId=188b89944917, content=疫情防控常态化,加速研发疫苗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d005416790, createdName=ms4000000561534892, createdTime=Mon Nov 16 08:08:12 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285951, encodeId=6c6b128595185, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Nov 15 22:46:09 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028778, encodeId=01531028e7825, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Nov 14 10:46:09 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899080, encodeId=ea628990806c, content=中国风险犹存, beContent=null, objectType=article, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Sat Nov 14 09:34:05 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899078, encodeId=6a0d8990e8ae, content=做好疫情防控!, beContent=null, objectType=article, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/72c91d73e2ce4d7b9c5c2632e334c6f9/2ca937aa7ec64d0a834d958d18104b30.jpg, createdBy=77a62581282, createdName=Ash.L, createdTime=Sat Nov 14 09:23:09 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899077, encodeId=e80a8990e7f4, content=好文章,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sat Nov 14 09:17:02 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899057, encodeId=d34f89905e9a, content=已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Sat Nov 14 08:43:45 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899055, encodeId=7ba0899055b4, content=没有疫苗是控制不住了, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200914/f1df8506d5cb4909bac2efc340b6c1fe/dcc6dd2dbec44613838b555fbe723804.jpg, createdBy=686b1371609, createdName=liyu7822, createdTime=Sat Nov 14 08:32:06 CST 2020, time=2020-11-14, status=1, ipAttribution=)]
    2020-11-14 lovetcm

    #新冠肺炎#,一些小国可以验证#群体免疫#的作用

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=899060, encodeId=0a0689906088, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>,一些小国可以验证<a href='/topic/show?id=44aa800289b' target=_blank style='color:#2F92EE;'>#群体免疫#</a>的作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=1201, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=80028, encryptionId=44aa800289b, topicName=群体免疫)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Nov 14 08:44:35 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899449, encodeId=188b89944917, content=疫情防控常态化,加速研发疫苗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d005416790, createdName=ms4000000561534892, createdTime=Mon Nov 16 08:08:12 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285951, encodeId=6c6b128595185, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Nov 15 22:46:09 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028778, encodeId=01531028e7825, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Nov 14 10:46:09 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899080, encodeId=ea628990806c, content=中国风险犹存, beContent=null, objectType=article, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Sat Nov 14 09:34:05 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899078, encodeId=6a0d8990e8ae, content=做好疫情防控!, beContent=null, objectType=article, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/72c91d73e2ce4d7b9c5c2632e334c6f9/2ca937aa7ec64d0a834d958d18104b30.jpg, createdBy=77a62581282, createdName=Ash.L, createdTime=Sat Nov 14 09:23:09 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899077, encodeId=e80a8990e7f4, content=好文章,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sat Nov 14 09:17:02 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899057, encodeId=d34f89905e9a, content=已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Sat Nov 14 08:43:45 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899055, encodeId=7ba0899055b4, content=没有疫苗是控制不住了, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200914/f1df8506d5cb4909bac2efc340b6c1fe/dcc6dd2dbec44613838b555fbe723804.jpg, createdBy=686b1371609, createdName=liyu7822, createdTime=Sat Nov 14 08:32:06 CST 2020, time=2020-11-14, status=1, ipAttribution=)]
    2020-11-16 ms4000000561534892

    疫情防控常态化,加速研发疫苗。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=899060, encodeId=0a0689906088, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>,一些小国可以验证<a href='/topic/show?id=44aa800289b' target=_blank style='color:#2F92EE;'>#群体免疫#</a>的作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=1201, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=80028, encryptionId=44aa800289b, topicName=群体免疫)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Nov 14 08:44:35 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899449, encodeId=188b89944917, content=疫情防控常态化,加速研发疫苗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d005416790, createdName=ms4000000561534892, createdTime=Mon Nov 16 08:08:12 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285951, encodeId=6c6b128595185, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Nov 15 22:46:09 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028778, encodeId=01531028e7825, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Nov 14 10:46:09 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899080, encodeId=ea628990806c, content=中国风险犹存, beContent=null, objectType=article, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Sat Nov 14 09:34:05 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899078, encodeId=6a0d8990e8ae, content=做好疫情防控!, beContent=null, objectType=article, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/72c91d73e2ce4d7b9c5c2632e334c6f9/2ca937aa7ec64d0a834d958d18104b30.jpg, createdBy=77a62581282, createdName=Ash.L, createdTime=Sat Nov 14 09:23:09 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899077, encodeId=e80a8990e7f4, content=好文章,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sat Nov 14 09:17:02 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899057, encodeId=d34f89905e9a, content=已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Sat Nov 14 08:43:45 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899055, encodeId=7ba0899055b4, content=没有疫苗是控制不住了, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200914/f1df8506d5cb4909bac2efc340b6c1fe/dcc6dd2dbec44613838b555fbe723804.jpg, createdBy=686b1371609, createdName=liyu7822, createdTime=Sat Nov 14 08:32:06 CST 2020, time=2020-11-14, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=899060, encodeId=0a0689906088, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>,一些小国可以验证<a href='/topic/show?id=44aa800289b' target=_blank style='color:#2F92EE;'>#群体免疫#</a>的作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=1201, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=80028, encryptionId=44aa800289b, topicName=群体免疫)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Nov 14 08:44:35 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899449, encodeId=188b89944917, content=疫情防控常态化,加速研发疫苗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d005416790, createdName=ms4000000561534892, createdTime=Mon Nov 16 08:08:12 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285951, encodeId=6c6b128595185, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Nov 15 22:46:09 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028778, encodeId=01531028e7825, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Nov 14 10:46:09 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899080, encodeId=ea628990806c, content=中国风险犹存, beContent=null, objectType=article, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Sat Nov 14 09:34:05 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899078, encodeId=6a0d8990e8ae, content=做好疫情防控!, beContent=null, objectType=article, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/72c91d73e2ce4d7b9c5c2632e334c6f9/2ca937aa7ec64d0a834d958d18104b30.jpg, createdBy=77a62581282, createdName=Ash.L, createdTime=Sat Nov 14 09:23:09 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899077, encodeId=e80a8990e7f4, content=好文章,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sat Nov 14 09:17:02 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899057, encodeId=d34f89905e9a, content=已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Sat Nov 14 08:43:45 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899055, encodeId=7ba0899055b4, content=没有疫苗是控制不住了, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200914/f1df8506d5cb4909bac2efc340b6c1fe/dcc6dd2dbec44613838b555fbe723804.jpg, createdBy=686b1371609, createdName=liyu7822, createdTime=Sat Nov 14 08:32:06 CST 2020, time=2020-11-14, status=1, ipAttribution=)]
    2020-11-14 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=899060, encodeId=0a0689906088, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>,一些小国可以验证<a href='/topic/show?id=44aa800289b' target=_blank style='color:#2F92EE;'>#群体免疫#</a>的作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=1201, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=80028, encryptionId=44aa800289b, topicName=群体免疫)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Nov 14 08:44:35 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899449, encodeId=188b89944917, content=疫情防控常态化,加速研发疫苗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d005416790, createdName=ms4000000561534892, createdTime=Mon Nov 16 08:08:12 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285951, encodeId=6c6b128595185, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Nov 15 22:46:09 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028778, encodeId=01531028e7825, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Nov 14 10:46:09 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899080, encodeId=ea628990806c, content=中国风险犹存, beContent=null, objectType=article, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Sat Nov 14 09:34:05 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899078, encodeId=6a0d8990e8ae, content=做好疫情防控!, beContent=null, objectType=article, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/72c91d73e2ce4d7b9c5c2632e334c6f9/2ca937aa7ec64d0a834d958d18104b30.jpg, createdBy=77a62581282, createdName=Ash.L, createdTime=Sat Nov 14 09:23:09 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899077, encodeId=e80a8990e7f4, content=好文章,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sat Nov 14 09:17:02 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899057, encodeId=d34f89905e9a, content=已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Sat Nov 14 08:43:45 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899055, encodeId=7ba0899055b4, content=没有疫苗是控制不住了, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200914/f1df8506d5cb4909bac2efc340b6c1fe/dcc6dd2dbec44613838b555fbe723804.jpg, createdBy=686b1371609, createdName=liyu7822, createdTime=Sat Nov 14 08:32:06 CST 2020, time=2020-11-14, status=1, ipAttribution=)]
    2020-11-14 神盾医疗局局长Jack

    中国风险犹存

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=899060, encodeId=0a0689906088, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>,一些小国可以验证<a href='/topic/show?id=44aa800289b' target=_blank style='color:#2F92EE;'>#群体免疫#</a>的作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=1201, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=80028, encryptionId=44aa800289b, topicName=群体免疫)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Nov 14 08:44:35 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899449, encodeId=188b89944917, content=疫情防控常态化,加速研发疫苗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d005416790, createdName=ms4000000561534892, createdTime=Mon Nov 16 08:08:12 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285951, encodeId=6c6b128595185, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Nov 15 22:46:09 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028778, encodeId=01531028e7825, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Nov 14 10:46:09 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899080, encodeId=ea628990806c, content=中国风险犹存, beContent=null, objectType=article, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Sat Nov 14 09:34:05 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899078, encodeId=6a0d8990e8ae, content=做好疫情防控!, beContent=null, objectType=article, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/72c91d73e2ce4d7b9c5c2632e334c6f9/2ca937aa7ec64d0a834d958d18104b30.jpg, createdBy=77a62581282, createdName=Ash.L, createdTime=Sat Nov 14 09:23:09 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899077, encodeId=e80a8990e7f4, content=好文章,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sat Nov 14 09:17:02 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899057, encodeId=d34f89905e9a, content=已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Sat Nov 14 08:43:45 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899055, encodeId=7ba0899055b4, content=没有疫苗是控制不住了, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200914/f1df8506d5cb4909bac2efc340b6c1fe/dcc6dd2dbec44613838b555fbe723804.jpg, createdBy=686b1371609, createdName=liyu7822, createdTime=Sat Nov 14 08:32:06 CST 2020, time=2020-11-14, status=1, ipAttribution=)]
    2020-11-14 Ash.L

    做好疫情防控!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=899060, encodeId=0a0689906088, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>,一些小国可以验证<a href='/topic/show?id=44aa800289b' target=_blank style='color:#2F92EE;'>#群体免疫#</a>的作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=1201, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=80028, encryptionId=44aa800289b, topicName=群体免疫)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Nov 14 08:44:35 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899449, encodeId=188b89944917, content=疫情防控常态化,加速研发疫苗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d005416790, createdName=ms4000000561534892, createdTime=Mon Nov 16 08:08:12 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285951, encodeId=6c6b128595185, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Nov 15 22:46:09 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028778, encodeId=01531028e7825, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Nov 14 10:46:09 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899080, encodeId=ea628990806c, content=中国风险犹存, beContent=null, objectType=article, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Sat Nov 14 09:34:05 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899078, encodeId=6a0d8990e8ae, content=做好疫情防控!, beContent=null, objectType=article, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/72c91d73e2ce4d7b9c5c2632e334c6f9/2ca937aa7ec64d0a834d958d18104b30.jpg, createdBy=77a62581282, createdName=Ash.L, createdTime=Sat Nov 14 09:23:09 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899077, encodeId=e80a8990e7f4, content=好文章,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sat Nov 14 09:17:02 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899057, encodeId=d34f89905e9a, content=已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Sat Nov 14 08:43:45 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899055, encodeId=7ba0899055b4, content=没有疫苗是控制不住了, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200914/f1df8506d5cb4909bac2efc340b6c1fe/dcc6dd2dbec44613838b555fbe723804.jpg, createdBy=686b1371609, createdName=liyu7822, createdTime=Sat Nov 14 08:32:06 CST 2020, time=2020-11-14, status=1, ipAttribution=)]
    2020-11-14 yangchou

    好文章,谢谢分享

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=899060, encodeId=0a0689906088, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>,一些小国可以验证<a href='/topic/show?id=44aa800289b' target=_blank style='color:#2F92EE;'>#群体免疫#</a>的作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=1201, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=80028, encryptionId=44aa800289b, topicName=群体免疫)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Nov 14 08:44:35 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899449, encodeId=188b89944917, content=疫情防控常态化,加速研发疫苗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d005416790, createdName=ms4000000561534892, createdTime=Mon Nov 16 08:08:12 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285951, encodeId=6c6b128595185, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Nov 15 22:46:09 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028778, encodeId=01531028e7825, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Nov 14 10:46:09 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899080, encodeId=ea628990806c, content=中国风险犹存, beContent=null, objectType=article, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Sat Nov 14 09:34:05 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899078, encodeId=6a0d8990e8ae, content=做好疫情防控!, beContent=null, objectType=article, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/72c91d73e2ce4d7b9c5c2632e334c6f9/2ca937aa7ec64d0a834d958d18104b30.jpg, createdBy=77a62581282, createdName=Ash.L, createdTime=Sat Nov 14 09:23:09 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899077, encodeId=e80a8990e7f4, content=好文章,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sat Nov 14 09:17:02 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899057, encodeId=d34f89905e9a, content=已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Sat Nov 14 08:43:45 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899055, encodeId=7ba0899055b4, content=没有疫苗是控制不住了, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200914/f1df8506d5cb4909bac2efc340b6c1fe/dcc6dd2dbec44613838b555fbe723804.jpg, createdBy=686b1371609, createdName=liyu7822, createdTime=Sat Nov 14 08:32:06 CST 2020, time=2020-11-14, status=1, ipAttribution=)]
    2020-11-14 医路前行4231

    已读

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=899060, encodeId=0a0689906088, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>,一些小国可以验证<a href='/topic/show?id=44aa800289b' target=_blank style='color:#2F92EE;'>#群体免疫#</a>的作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=1201, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=80028, encryptionId=44aa800289b, topicName=群体免疫)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sat Nov 14 08:44:35 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899449, encodeId=188b89944917, content=疫情防控常态化,加速研发疫苗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d005416790, createdName=ms4000000561534892, createdTime=Mon Nov 16 08:08:12 CST 2020, time=2020-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285951, encodeId=6c6b128595185, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Nov 15 22:46:09 CST 2020, time=2020-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028778, encodeId=01531028e7825, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Nov 14 10:46:09 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899080, encodeId=ea628990806c, content=中国风险犹存, beContent=null, objectType=article, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Sat Nov 14 09:34:05 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899078, encodeId=6a0d8990e8ae, content=做好疫情防控!, beContent=null, objectType=article, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/72c91d73e2ce4d7b9c5c2632e334c6f9/2ca937aa7ec64d0a834d958d18104b30.jpg, createdBy=77a62581282, createdName=Ash.L, createdTime=Sat Nov 14 09:23:09 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899077, encodeId=e80a8990e7f4, content=好文章,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Sat Nov 14 09:17:02 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899057, encodeId=d34f89905e9a, content=已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM6tia9pyZiaPziaeLHadUZP17uiav8DTro6peFy5lvuO5EjYrG4ButKWVynGX1CUFFBbXhib9bjE77pkHw/132, createdBy=41785253089, createdName=医路前行4231, createdTime=Sat Nov 14 08:43:45 CST 2020, time=2020-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899055, encodeId=7ba0899055b4, content=没有疫苗是控制不住了, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200914/f1df8506d5cb4909bac2efc340b6c1fe/dcc6dd2dbec44613838b555fbe723804.jpg, createdBy=686b1371609, createdName=liyu7822, createdTime=Sat Nov 14 08:32:06 CST 2020, time=2020-11-14, status=1, ipAttribution=)]
    2020-11-14 liyu7822

    没有疫苗是控制不住了

    0

相关资讯

Cell Discovery:深圳三院与华大研究院揭示,新冠患者症状严重程度与遗传因素有关

本研究成果的发布将有力推动新冠相关的基础科学研究,所发现的遗传背景差异将为科研人员进一步认识新冠病毒及其与人体的相互作用机制提供指引,进而为科学防控新冠肺炎疫情提供参考。

2020年11月13日全球新冠肺炎(COVID-19)疫情简报,确诊超5303万,各方期待疫苗问世

据称Worldometers实时统计数据显示,截至北京时间11月13日05时48分,全球新冠肺炎(COVID-19)确诊病例达5303万例,新增608,366例至53,039,054例,死亡病例达12

Lancet respirat med:雾化吸入干扰素β-1a可大大改善新冠肺炎患者病情并加速恢复

重度急性呼吸窘迫综合症冠状病毒2(SARS-CoV-2)感染会带来严重和长期的疾病风险;目前治疗方法有限。Monk等评估了雾化吸入干扰素β-1a(SNG001)治疗因COVID-19入院的患

2020年11月12日全球新冠肺炎(COVID-19)疫情简报,确诊超5237万,中国国药疫苗数据好于预期

据称Worldometers实时统计数据显示,截至北京时间11月12日07时01分,全球新冠肺炎(COVID-19)确诊病例达5237万例,新增570,835例至52,379,008例,死亡病例达12

NEJM:mRNA疫苗mRNA-1273用于新冠肺炎的预防研究

mRNA-1273疫苗可诱导了抗SARS-CoV-2免疫应答,疫苗的安全性和耐受性良好,有进一步开发的潜力

Science:重磅:极大关注,首次发现动物可将新冠病毒传播给人类

动物实验表明,非人类灵长类动物,猫,雪貂,仓鼠,兔和蝙蝠可被SARS-CoV-2感染。此外,在野外还发现了猫,貂和狗的SARS-CoV-2 RNA。